Cytokinetics
CYTK
#2440
Rank
โ‚น659.95 B
Marketcap
โ‚น4,738
Share price
-1.32%
Change (1 day)
-17.56%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): -โ‚น564.57

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -โ‚น563.50. In 2025 the company made an earnings per share (EPS) of -โ‚น609.22 a decrease over its 2024 EPS that were of -โ‚น490.73.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น564.57-7.33%
2025-โ‚น609.2224.14%
2024-โ‚น490.73-3.49%
2023-โ‚น508.4628.24%
2022-โ‚น396.5050.18%
2021-โ‚น264.0240.8%
2020-โ‚น187.52
2018-โ‚น181.93-24.12%
2017-โ‚น239.77-776.32%
2016โ‚น35.45-139.18%
2015-โ‚น90.50125.58%
2014-โ‚น40.12-67.67%
2013-โ‚น124.08-44.58%
2012-โ‚น223.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,621-387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-โ‚น3,241 475.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น241.63-142.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น4,694 732.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น107.29-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA